A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

5 ',5 '-Phosphodiesters and esterase labile triesters of 2 '-C-methylribonucleosides




TekijätLeisvuori A, Ahmed Z, Ora M, Blatt L, Beigelman L, Lonnberg H

KustantajaARKAT USA INC

Julkaisuvuosi2012

JournalArkivoc

Tietokannassa oleva lehden nimiARKIVOC

Lehden akronyymiARKIVOC

Numero5

Aloitussivu226

Lopetussivu243

Sivujen määrä18

ISSN1551-7004

DOIhttps://doi.org/10.3998/ark.5550190.0013.520

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/3182820


Tiivistelmä
Bis(2'-C-methyladenosin-5'-yl) (11), bis(2'-C-methylguanosin-5'-yl) (13), bis(2'-C-methyluridin-5'-yl) (15) and 2'-C-methylguanosin-5'-yl 2'-C-methyluridin-5'-yl (16) phosphodiesters have been prepared as pro-drug candidates for the respective 2'-C-methylribonucleoside 5'-monophosphates, expectedly exhibiting antiviral activity against Hepatitis C virus. Additionally, the bis(2'-C-methyladenosine) diester has been converted to 3-acetyloxymethoxy-2,2-bis(ethoxycarbonyl)propyl (19) or pivaloyloxymethyl (20) triester. The underlying idea is that the 5',5'-phosphodiester is first released by intracellular carboxyesterases and subsequently cleaved to nucleoside and nucleoside 5'-monophosphate by phosphodiesterases.


Research Areas


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 18:09